Tactile Systems Technology, Inc. (FRA:3L3)
Germany · Delayed Price · Currency is EUR | Market Cap | 520.05M +83.3% |
| Revenue (ttm) | 280.65M +12.5% |
| Net Income | 16.26M +12.5% |
| EPS | 0.70 +17.1% |
| Shares Out | n/a |
| PE Ratio | 31.99 |
| Forward PE | 23.41 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 5 |
| Open | 23.00 |
| Previous Close | 23.00 |
| Day's Range | 23.00 - 23.00 |
| 52-Week Range | 8.00 - 28.80 |
| Beta | n/a |
| RSI | 44.54 |
| Earnings Date | May 4, 2026 |
About FRA:3L3
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic comp... [Read more]
Financial Performance
In 2025, FRA:3L3's revenue was $329.52 million, an increase of 12.47% compared to the previous year's $292.98 million. Earnings were $19.09 million, an increase of 12.54%.
Financial numbers in USD Financial StatementsNews
Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson
MINNEAPOLIS, March 09, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chr...
Tactile Systems Technology Analysts Raise Their Forecasts After Better-Than-Expected Q4 Earnings
Tactile Systems reported fourth-quarter earnings of 46 cents, better than the consensus of 44 cents. Sales jumped 21% to $103.59 million, beating the Wall Street estimates of $93.80 million, attributa...
Tactile Systems Technology, Inc. (TCMD) Q4 2025 Earnings Call Transcript
Tactile Systems Technology, Inc. (TCMD) Q4 2025 Earnings Call Transcript
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio
LymphaTech's 3D Platform and Digital Capabilities to Improve Disease Identification, Accelerate Therapy Adoption, and Support Next-Generation Lymphatic Therapies LymphaTech's 3D Platform and Digital C...
Tactile Medical to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026
MINNEAPOLIS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Medical to Present at the Piper Sandler 37th Annual Healthcare Conference
MINNEAPOLIS, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Systems Technology Analysts Increase Their Forecasts After Better-Than-Expected Q3 Earnings
Tactile Systems Technology Inc (NASDAQ:TCMD) reported upbeat third-quarter earnings and raised FY2025 sales guidance on Monday.
Tactile Systems Technology, Inc. (TCMD) Q3 2025 Earnings Call Transcript
Tactile Systems Technology, Inc. ( TCMD) Q3 2025 Earnings Call November 3, 2025 5:00 PM EST Company Participants Sheri Dodd - CEO, President & Director Elaine Birkemeyer - Chief Financial Officer Con...
Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results
MINNEAPOLIS, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema
MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025
MINNEAPOLIS, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Systems Technology, Inc. (TCMD) Q2 2025 Earnings Call Transcript
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q2 2025 Earnings Conference Call August 4, 2025 5:00 PM ET Company Participants Elaine M. Birkemeyer - Chief Financial Officer Sheri Louise Dodd - CEO, ...
Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results
MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Medical to Release Second Quarter of Fiscal Year 2025 Financial Results on August 4, 2025
MINNEAPOLIS, July 21, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors
Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer Survivors Abstract Presented at ASCO 2025 Annual Meet...
Tactile Medical to Present at Upcoming Investor Conferences in June
MINNEAPOLIS, May 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chron...
Tactile Systems Stock Tumbles As Q1 Earnings Fall Short Of Expectations
Tactile Systems Technology, Inc. TCMD traded lower on Tuesday after the company's Q1 earnings missed Wall Street expectations on Monday.
Tactile Systems Technology, Inc. (TCMD) Q1 2025 Earnings Call Transcript
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q1 2025 Earnings Conference Call May 5, 2025 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - Chief...
Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results
MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chron...
Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025
MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chr...
Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
MINNEAPOLIS, March 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chr...
Tactile Systems Technology, Inc. (TCMD) Q4 2024 Earnings Call Transcript
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q4 2024 Earnings Conference Call February 18, 2025 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd -...
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
MINNEAPOLIS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...
Tactile Medical to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 18, 2025
MINNEAPOLIS, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chro...